A low AMH result often creates immediate anxiety:
Does this mean my eggs are poor quality, and is natural pregnancy now unlikely?
Not necessarily.
Diminished ovarian reserve, or DOR, primarily refers to a lower quantity of remaining oocytes or a lower expected ovarian response to stimulation than would typically be expected for a woman of similar age.
Egg quality is a different concept. It refers to the biological and chromosomal competence of an oocyte and is influenced much more strongly by maternal age.
ASRM emphasises that AMH and antral follicle count are useful for predicting oocyte yield during ovarian stimulation but are relatively poor independent predictors of pregnancy and live birth.
A low AMH result should therefore not be translated into:
low AMH = poor-quality eggs = pregnancy is impossible.
What is ovarian reserve?
Ovarian reserve refers mainly to the quantity of oocytes remaining within the ovaries.
The number declines naturally over reproductive life, but women of the same chronological age can have substantially different ovarian reserves.
ASRM specifically distinguishes oocyte quantity, which ovarian-reserve testing is designed to estimate, from oocyte quality, which describes the potential of an oocyte to contribute to a live birth.
What is diminished ovarian reserve?
DOR describes a lower-than-expected ovarian reserve or expected response to ovarian stimulation.
A woman can still:
Have regular periods.
Ovulate.
Conceive naturally.
despite having a low AMH.
ASRM describes DOR in reproductive-age women as reduced ovarian responsiveness relative to women of similar age and stresses that poor ovarian-reserve testing does not necessarily mean inability to conceive.
Is AMH alone enough?
AMH is highly useful but should not be interpreted in isolation.
The fertility team may also consider:
Age.
Antral follicle count.
Previous ovarian surgery.
Previous IVF response.
Menstrual pattern.
Reproductive history.
Endometriosis.
Other medical factors.
Hormonal contraception can also lower measured AMH in some women, so results require clinical context.
What is antral follicle count?
AFC is the number of small antral follicles seen in both ovaries on transvaginal ultrasound.
Together with AMH, it is one of the most useful tools for predicting ovarian response and expected oocyte yield.
ASRM considers AMH and AFC broadly comparable markers when performed and interpreted appropriately.
What about FSH?
Basal FSH has historically been used as an ovarian-reserve marker.
It may rise as the follicular pool declines, but AMH tends to become abnormal earlier.
A normal FSH therefore does not necessarily exclude diminished reserve.
FSH also needs to be interpreted together with estradiol and cycle timing.
Does low AMH mean poor egg quality?
No, not automatically.
AMH and AFC primarily provide information about quantity and expected response.
Age has a much stronger relationship with the chromosomal competence of oocytes.
A 30-year-old woman with low AMH may retrieve only a few oocytes during IVF, but those oocytes should not automatically be assumed to have the same age-related prognosis as oocytes from a woman in her early forties.
ASRM reports only weak associations between ovarian-reserve markers and qualitative outcomes such as oocyte quality, pregnancy and live birth.
Why does age matter so much?
As oocyte age increases, chromosomal abnormalities become more common.
Maternal age therefore strongly influences:
Embryo aneuploidy.
Pregnancy probability.
Miscarriage.
Live birth.
AMH answers a different question:
How many follicles and oocytes might we have available?
It does not directly tell us whether every available oocyte is chromosomally normal.
Can natural pregnancy occur with low AMH?
Yes.
Ovarian-reserve markers have performed poorly as independent predictors of spontaneous conception.
ASRM notes that prospective studies found women with low AMH could have cumulative natural-pregnancy rates similar to women with normal AMH in the studied populations.
Low AMH should therefore not be used as a yes-or-no fertility test.
Why does low ovarian reserve matter for IVF?
Its strongest clinical value is in predicting response to ovarian stimulation.
A woman with DOR may produce:
Fewer growing follicles.
Fewer retrieved oocytes.
Fewer mature oocytes.
Consequently fewer opportunities to generate embryos.
This information helps the team plan stimulation and counsel realistically.
ESHRE's updated ovarian-stimulation guideline specifically focuses on individualising treatment according to expected ovarian response.
Does very low AMH mean IVF will fail?
No.
ASRM explicitly states that extremely low AMH values should not be used to refuse IVF treatment.
The main implication is usually a lower expected oocyte yield, not zero possibility of pregnancy.
Some patients may need more than one retrieval to obtain the number of oocytes or embryos they are hoping for.
What is poor ovarian response?
Poor ovarian response refers to a low response to stimulation, resulting in relatively few developing follicles or retrieved oocytes.
It can sometimes be predicted using AMH and AFC, but actual response to a previous stimulation cycle can be even more informative for planning future treatment.
Does every woman with low AMH respond poorly?
No.
AMH predicts probability, not certainty.
Some women respond better than expected and others less well.
A previous stimulation cycle therefore provides valuable individual information.
Will very high doses of stimulation overcome DOR?
Not indefinitely.
Medication stimulates follicles that are already available during that cycle.
Increasing gonadotropin doses cannot create a new ovarian follicular pool.
ESHRE's current guidance emphasises individualised ovarian stimulation rather than assuming that continually increasing medication will necessarily generate more oocytes.
Can ovarian reserve be increased?
There is currently no proven treatment that regenerates the ovarian reserve.
Stimulation can recruit follicles that are available, but it does not recreate the oocytes that have already been lost naturally over time.
Claims that a treatment can permanently:
Restore AMH.
Rejuvenate the ovaries.
Replace lost eggs.
Rebuild ovarian reserve.
should therefore be approached cautiously.
Can supplements increase ovarian reserve?
No supplement has been proven to regenerate ovarian reserve.
Some supplements are studied for metabolic or cellular aspects of oocyte function, and correcting a nutritional deficiency may be appropriate.
That is very different from creating new oocytes.
What causes diminished ovarian reserve?
Possible contributors include:
Reproductive ageing.
Natural individual variation.
Endometriosis and ovarian endometriomas.
Previous ovarian surgery.
Chemotherapy or radiotherapy.
Some genetic conditions.
Certain medical or autoimmune conditions.
Unknown causes.
In many women, no single cause is identified.
Can ovarian surgery lower reserve?
Yes.
The risk is particularly relevant after:
Endometrioma surgery.
Repeat ovarian procedures.
Bilateral ovarian surgery.
Preserving normal ovarian tissue therefore matters when surgical treatment is being considered in women who want future fertility.
When should treatment not be delayed?
Low AMH alone does not determine urgency.
However, prolonged waiting becomes less attractive when low reserve occurs together with:
Advancing age.
Long-standing infertility.
Tubal disease.
Male-factor infertility.
Endometriosis.
Previous ovarian surgery.
Very low AFC.
Previous poor response.
In these situations, reproductive time may itself become an important part of prognosis.
When does IVF make sense?
IVF may be discussed earlier when there is a need to:
Use reproductive time efficiently.
Recruit several available follicles during one cycle.
Bypass tubal disease.
Treat significant male factor.
Create embryos for future use.
Assess actual ovarian response.
There is no single AMH cut-off that automatically means IVF is required.
Is IUI still possible?
In selected younger women with patent tubes, ovulation and no major male factor, IUI may still be reasonable.
The choice between expectant management, IUI and IVF should depend on the complete fertility picture rather than AMH alone.
Should eggs be frozen?
That depends heavily on age and reproductive plans.
Egg freezing does not treat DOR, but it can preserve oocytes retrieved now for possible future use.
When reserve is already low, however, fewer oocytes may be collected per cycle and more than one retrieval may sometimes be required.
ASRM emphasises that planned oocyte cryopreservation decisions should rely strongly on age and reproductive planning rather than ovarian-reserve markers alone.
What is DuoStim?
DuoStim refers to two ovarian-stimulation phases performed within a short interval, often one in the follicular phase and another in the luteal phase.
Its purpose is to obtain more oocytes within a shorter period.
It does not regenerate ovarian reserve.
ESHRE's 2025 guideline discusses double stimulation particularly in time-sensitive fertility-preservation settings, where obtaining more oocytes quickly may be useful, while evidence for broader applications remains more limited.
Is DuoStim best for every poor responder?
No.
It may be considered when time is important or when accumulating oocytes or embryos quickly has a clear purpose.
The advantages must be weighed against additional medication, treatment burden, cost and alternative approaches.
Can embryos or oocytes be accumulated over several cycles?
Yes.
Some patients with low oocyte yield discuss multiple retrievals before moving to transfer or another stage of treatment.
Accumulation increases the number of available oocytes or embryos but does not reverse the age-related biology of the eggs.
What is the difference between DOR and POI?
This distinction is essential.
Diminished ovarian reserve
There are fewer remaining follicles or a lower expected response, but menstruation and ovulation can remain regular.
Premature ovarian insufficiency
POI involves loss of normal ovarian function before age 40, typically associated with irregular or absent menstrual cycles and biochemical confirmation of ovarian insufficiency.
The updated international ESHRE guideline defines POI on this clinical and biochemical basis.
Therefore:
low AMH alone does not diagnose POI.
Is AMH used to diagnose POI?
Not as the primary diagnostic test.
The 2024 international POI guideline states that AMH should not be used as the primary test for diagnosis.
It may provide additional information when FSH findings are inconclusive, but only within the appropriate clinical context.
Do regular periods prove ovarian reserve is normal?
No.
A woman may continue to have regular ovulatory cycles while AMH and AFC decline.
Menstrual regularity and ovarian reserve describe related but different aspects of ovarian function.
Does low AMH predict when menopause will happen?
Not accurately enough for an individual woman.
The POI guideline does not recommend routine AMH testing to predict who will develop POI because predictive accuracy is insufficient.
A single AMH result therefore cannot reliably tell someone exactly how many reproductive years remain.
Can AMH fluctuate?
Yes.
Values can vary with:
Assay and laboratory.
Hormonal contraception.
Biological variability.
Other clinical factors.
Small changes should not automatically be interpreted as ovarian recovery or rapid deterioration.
Does low reserve mean PGT-A is necessary?
No.
PGT-A does not treat diminished ovarian reserve or increase the number of embryos produced.
The decision should depend on age, embryo number, reproductive history and the benefits and limitations of testing rather than AMH alone.
Why does low egg number matter if quality can still be good?
Because every stage involves biological attrition.
Not every:
Follicle contains an oocyte.
Retrieved oocyte is mature.
Mature oocyte fertilises.
Fertilised oocyte becomes a blastocyst.
Blastocyst results in a live birth.
Starting with fewer oocytes therefore means fewer opportunities overall, even when the individual oocytes are not automatically poor quality.
Why is a young woman with low AMH different from an older woman?
A young woman with DOR may face primarily a quantity problem.
An older woman with the same low oocyte yield may face both a quantity problem and a higher age-related probability of chromosomal abnormalities.
This is why age remains central to prognosis.
Useful questions after a low AMH result
Ask:
Does my AMH agree with my AFC?
What does this result mean for my age?
Am I still ovulating regularly?
Is there a possible reason for reduced reserve?
Are my fallopian tubes suitable?
What does the semen analysis show?
Is natural trying, IUI or IVF more appropriate?
If we perform IVF, what ovarian response is realistically expected?
Would more than one retrieval be reasonable?
Should egg or embryo freezing be considered?
Are any add-on treatments being suggested, and what evidence supports them?
Conclusion
Diminished ovarian reserve primarily means a lower quantity of available oocytes or a lower expected ovarian response. It does not automatically mean that the remaining eggs are poor quality or that natural pregnancy is impossible.
AMH and AFC are among the best available tools for predicting ovarian response and oocyte yield during IVF, but their independent ability to predict pregnancy and live birth is limited. Age remains one of the strongest determinants of reproductive prognosis.
DOR should also not be confused with premature ovarian insufficiency. POI requires a clinical pattern of impaired ovarian function before age 40, and AMH alone should not be used to diagnose it.
If you have a low AMH or low AFC, Safemedigo can coordinate review of your age, ultrasound, fertility history, laboratory results and semen analysis with the fertility team to determine whether natural trying, IVF, egg freezing or embryo freezing is the most appropriate next step. Contact Safemedigo on WhatsApp.
Frequently Asked Questions
Does low AMH mean poor egg quality?
No. AMH mainly reflects follicle quantity and expected ovarian response, while egg quality is much more strongly influenced by age and other biological factors.
Can I become pregnant naturally with diminished ovarian reserve?
Yes. DOR does not mean that ovulation has stopped or that natural pregnancy is impossible. Age and other fertility factors remain important.
Does a low AMH automatically mean I need IVF?
No. IVF decisions should consider age, infertility duration, AFC, tubal status, semen findings and reproductive plans rather than one AMH value.
Can medication or supplements rebuild ovarian reserve?
No proven treatment can recreate the ovarian follicle pool. Stimulation recruits follicles that already exist but does not generate a new reserve.
Is low AMH the same as premature ovarian insufficiency?
No. Low AMH alone does not diagnose POI. POI involves impaired ovarian function before age 40 together with the appropriate menstrual and biochemical findings.
